You have 9 free searches left this month | for more free features.

City

Boston (1)

Houston (1)

Pittsburgh (1)

Condition

Acute Myeloid Leukemia Refractory (1)

Acute Myeloid Leukemia, in Relapse (1)

Neuroendocrine Carcinoma (1)

Small-cell Lung Cancer (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Fox Chase Cancer Center (1)

Oryzon Genomics S.A. (1)

Collaborator

Intervention

iadademstat (2)

gilteritinib oral tablet (1)

paclitaxel (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

iadademstat

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Boston (Iadademstat, Gilteritinib Oral Tablet)

Recruiting

Acute Myeloid Leukemia, in Relapse
Acute Myeloid Leukemia Refractory

Iadademstat
Gilteritinib Oral Tablet

Boston, Massachusetts
+2 more

Jan 18, 2023

Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

Not yet recruiting

Small-cell Lung Cancer
Neuroendocrine Carcinoma

Iadademstat
Paclitaxel

(no location specified)

Jun 13, 2022